Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient.
Masoud Mohammad MalekzadehReza AlizadehZiba AghsaeifardMohammad Ali SahraianPublished in: Clinical case reports (2020)
A 43-year-old man who was treated with interferon-beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in renal function, no such improvement was seen in patient.